ASCEND WELLNESS HOLDINGS, INC. Financials Ascend Wellness Holdings, Inc. OTC Markets
Equities
AAWH
US04351N1063
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.3 USD | -4.41% |
|
0.00% | +30.00% |
| 05-07 | Transcript : Ascend Wellness Holdings, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
| 05-07 | Earnings Flash (AAWH) ASCEND WELLNESS HOLDINGS Reports Q1 Revenue $142.4M | MT |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,145 | 217 | 200.7 | 278.7 | - | - |
| Enterprise Value (EV) 1 | 1,448 | 705.9 | 200.7 | 587.8 | 544.1 | 671.7 |
| P/E ratio | - | -2.61 x | -4.04 x | -6.39 x | -14 x | -10.1 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 3.45 x | 0.53 x | 0.39 x | 0.48 x | 0.45 x | 0.42 x |
| EV / Revenue | 4.36 x | 1.74 x | 0.39 x | 1 x | 0.88 x | 1 x |
| EV / EBITDA | 18.2 x | 7.57 x | 1.88 x | 4.62 x | 3.77 x | 4.38 x |
| EV / FCF | -11.1 x | -5.88 x | - | 26.8 x | 12.5 x | 13.7 x |
| FCF Yield | -8.99% | -17% | - | 3.73% | 8.01% | 7.3% |
| Price to Book | 6.43 x | 1.29 x | - | 2.34 x | 2.57 x | 2.85 x |
| Nbr of stocks (in thousands) | 173,248 | 188,662 | 206,871 | 212,727 | - | - |
| Reference price 2 | 6.610 | 1.150 | 0.9700 | 1.310 | 1.310 | 1.310 |
| Announcement Date | 22-03-08 | 23-03-14 | 24-03-12 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 143.7 | 332.4 | 405.9 | 518.6 | 585.6 | 618 | 669.2 |
| EBITDA 1 | - | 79.43 | 93.22 | 106.5 | 127.1 | 144.5 | 153.4 |
| EBIT 1 | - | -17.2 | -7.526 | -3.619 | 28.33 | 54 | 74 |
| Operating Margin | - | -5.18% | -1.85% | -0.7% | 4.84% | 8.74% | 11.06% |
| Earnings before Tax (EBT) 1 | - | - | -39.21 | -14.76 | - | - | - |
| Net income 1 | -25.44 | - | -80.9 | -48.21 | -39.4 | -12.05 | - |
| Net margin | -17.7% | - | -19.93% | -9.3% | -6.73% | -1.95% | - |
| EPS 2 | -0.1300 | - | -0.4400 | -0.2400 | -0.2050 | -0.0933 | -0.1300 |
| Free Cash Flow 1 | - | -130.2 | -120 | - | 21.95 | 43.58 | 49 |
| FCF margin | - | -39.16% | -29.56% | - | 3.75% | 7.05% | 7.32% |
| FCF Conversion (EBITDA) | - | - | - | - | 17.27% | 30.16% | 31.93% |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 21-02-26 | 22-03-08 | 23-03-14 | 24-03-12 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 88.5 | 85.09 | 97.5 | 111.2 | 112.1 | 114.2 | 123 | 141.3 | 140.2 | 142.4 | 145.4 | 148 | 150.5 | 154 | 156.6 |
| EBITDA 1 | 19.76 | 16.37 | 20.89 | 27.77 | 28.19 | 23.31 | 21.32 | 29.52 | 32.35 | 32.48 | 31.11 | 32 | 32.17 | 33.77 | 35.8 |
| EBIT 1 | -0.731 | -14.78 | -0.605 | 2.477 | 5.382 | 0.255 | -7.985 | 3.547 | 0.564 | 2.575 | 5.967 | 7.067 | 6.233 | - | - |
| Operating Margin | -0.83% | -17.37% | -0.62% | 2.23% | 4.8% | 0.22% | -6.49% | 2.51% | 0.4% | 1.81% | 4.1% | 4.78% | 4.14% | - | - |
| Earnings before Tax (EBT) 1 | - | - | -9.7 | -5.684 | -3.114 | -8.455 | 5.578 | -4.514 | -7.369 | -5.653 | -7.9 | -8.2 | -7.5 | - | - |
| Net income 1 | - | - | -21.17 | -16.86 | -15.05 | -18.74 | 0.841 | -11.24 | -19.34 | -18.16 | -17 | -16.55 | -15.95 | - | - |
| Net margin | - | - | -21.72% | -15.16% | -13.43% | -16.42% | 0.68% | -7.96% | -13.8% | -12.75% | -11.69% | -11.18% | -10.6% | - | - |
| EPS 2 | - | - | -0.1100 | -0.0900 | -0.0800 | -0.1000 | 0.004300 | -0.0500 | -0.0900 | -0.0900 | -0.0600 | -0.0550 | -0.0550 | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 22-03-08 | 22-05-11 | 22-08-15 | 22-11-10 | 23-03-14 | 23-05-09 | 23-08-08 | 23-11-07 | 24-03-12 | 24-05-07 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 303 | 489 | - | 309 | 265 | 393 |
| Net Cash position 1 | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 3.818 x | 5.245 x | - | 2.432 x | 1.837 x | 2.561 x |
| Free Cash Flow 1 | - | -130 | -120 | - | 22 | 43.6 | 49 |
| ROE (net income / shareholders' equity) | - | -76.4% | - | - | -17.5% | -4.8% | - |
| ROA (Net income/ Total Assets) | - | -12% | - | - | 7.3% | 8.4% | - |
| Assets 1 | - | - | - | - | -539.7 | -143.5 | - |
| Book Value Per Share 2 | - | 1.030 | 0.8900 | - | 0.5600 | 0.5100 | 0.4600 |
| Cash Flow per Share 2 | - | -0.2800 | -0.2100 | - | 0.3200 | 0.3900 | - |
| Capex 1 | - | 88.4 | 81.6 | - | 34.9 | 22 | 10 |
| Capex / Sales | - | 26.6% | 20.11% | - | 5.95% | 3.56% | 1.49% |
| Announcement Date | 21-02-26 | 22-03-08 | 23-03-14 | 24-03-12 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
1.31
USD
Average target price
3.406
USD
Spread / Average Target
+160.02%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -37.75% | 341M | |
| -.--% | 339M | |
| +52.26% | 299M | |
| +57.56% | 206M | |
| +52.17% | 138M | |
| +140.77% | 137M | |
| -28.57% | 122M | |
| +34.62% | 118M | |
| +100.00% | 60.26M |
- Stock Market
- Equities
- AAWH.U Stock
- AAWH Stock
- Financials Ascend Wellness Holdings, Inc.